showed a trendp = 0.1264
SNORA68 showed a trend to downregulation between stage I and IV ( p = 0.1264) and between stage II and IV ( p = 0.0790).
SNORA68 showed a trend to downregulation between stage I and IV ( p = 0.1264) and between stage II and IV ( p = 0.0790).
Expression levels of RNU2-1, SCARNA3, and SNORD15B were also higher in Ki-67-positive samples at both cut-offs, although these differences did not reach statistical significance.
The significantly lower expression of RNU2-1 in lymph node metastasis-positive samples, along with a decreasing trend observed for SCARNA2, SNORD15B, and SNORD94, as well as the reduced expression of SNORD15B in multifocality-positive samples, all support the presumed tumor suppressor roles of these genes.